CD8α, or CD8 alpha, is a protein predominantly found on the surface of immune cells, particularly a subset of T cells known as cytotoxic T lymphocytes. The role of CD8α is to act as a co-receptor alongside the T-cell receptor in recognizing antigens presented by the Major Histocompatibility Complex class I molecules on the surface of infected or dysfunctional cells. This interaction is essential for the activation of cytotoxic T cells, which subsequently can lead to the targeted killing of cells that are deemed a threat, such as virally infected cells or tumor cells. The presence of CD8α is, therefore, a critical component in the immune system's ability to maintain surveillance against pathogens and cellular abnormalities. The regulation of CD8α expression is a finely tuned process, influenced by a variety of internal signals within the immune system, which ensures that CD8α is expressed at the right time and place, enabling an effective immune response.
A number of specific chemicals have been identified that can potentially induce the expression of CD8α, serving as activators in the immunological context. These activators encompass a broad range of compounds, including molecules naturally occurring within the body as well as synthetic compounds. For instance, Prostaglandin E2, a lipid compound with hormone-like activity, is known to have broad regulatory functions in immunity which could include upregulating the expression of proteins like CD8α. Similarly, synthetic compounds such as Poly I:C, a mimic of viral genetic material, can activate immune responses, potentially leading to increased CD8α expression as part of the body's simulation of a viral defense mechanism. Other compounds such as beta-glucans, found in the cell walls of bacteria and fungi, and various nutritional supplements like Vitamin D3 and Zinc gluconate, have been shown to influence the immune system, which includes the modulation of surface proteins on immune cells. It's important to note that while these compounds are recognized for their role in the broader context of immune function, the precise pathways through which they influence CD8α expression are complex and are a subject of ongoing scientific investigation.
Items 11 to 16 of 16 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Phosphoinositide 3-kinase (PI3K) inhibitor that influences the PI3K-AKT pathway, indirectly enhancing CD8-α signaling by regulating downstream pathways involved in T cell activation. | ||||||
Isoprinosine | 36703-88-5 | sc-279232 sc-279232A sc-279232B | 10 mg 100 mg 1 g | $120.00 $210.00 $270.00 | ||
Isoprinosine may stimulate immune function, which includes the induction of CD8α expression as a marker of immune cell activation. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $38.00 $1155.00 $122.00 | 3 | |
Potassium channel blocker that prolongs the duration of action potentials in T cells, directly enhancing CD8-α+ T cell activation and effector functions. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc gluconate plays a crucial role in maintaining T cell function, which may include the stimulation of CD8α expression on the surface of these cells. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum kinase inhibitor that affects various signaling pathways, indirectly influencing CD8-α+ T cell activation by modulating multiple kinases involved in T cell receptor signaling. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Protein kinase C (PKC) inhibitor that impacts T cell activation, indirectly enhancing CD8-α activity by modulating PKC-dependent signaling pathways in T cells. | ||||||